Next-generation sequencing: Emerging lessons on the origins of human cancer

Current Opinion in Oncology

Volumn 23, Issue 1, 2011, Pages 62-68

  Pfeifer, Gerd R ^a   Hainaut, Pierre ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Carcinogens; Massive parallel sequencing; Mutation patterns; Next generation sequencing; TP53

Indexed keywords

APC PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CARCINOGEN; CHECKPOINT KINASE 2; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 1; NICOTINIC RECEPTOR; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; ENVIRONMENTAL FACTOR; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLIOBLASTOMA; HEREDITY; HUMAN; HUMAN GENOME; LUNG CANCER; MELANOMA; NEOPLASM; PHYLOGENY; PRIORITY JOURNAL; RADIATION EXPOSURE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION;

GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 79851507487     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e3283414d00     Document Type: Article

References (31)

1. Pfeifer GP, Besaratinia A. Mutational spectra of human cancer. Hum Genet 2009; 125:493-506.
2. Hainaut P, Hollstein M. p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 2000; 77:81-137. (Pubitemid 29439303)
3. Shuga J, Zeng Y, Novak R, et al. Selected technologies for measuring acquired genetic damage in humans. Environ Mol Mutagen 2010; 51:851-870.
4. Davalos V, Esteller M. MicroRNAs and cancer epigenetics: a macrorevolution. Curr Opin Oncol 2010; 22:35-45.
5. Espada J, Esteller M. DNA methylation and the functional organization of the nuclear compartment. Semin Cell Dev Biol 2010; 21:238-246.
6. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921. (Pubitemid 32165345)
7. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001; 291:1304-1351. (Pubitemid 32173090)
8. Metzker ML. Sequencing technologies: the next generation. Nat Rev Genet 2010; 11:31-46.
9. Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 2010; 11:685-696.
10. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343:78-85. (Pubitemid 30451850)
11. Lindor NM, McMaster ML, Lindor CJ, Greene MH. Concise handbook of familial cancer susceptibility syndromes: second edition. J Natl Cancer Inst Monogr 2008; 38:1-93.
12. Bodmer W, Tomlinson I. Rare genetic variants and the risk of cancer. Curr Opin Genet Dev 2010; 20:262-267.
13. Cazier JB, Tomlinson I. General lessons from large-scale studies to identify human cancer predisposition genes. J Pathol 2010; 220:255-262.
14. Varghese JS, Easton DF. Genome-wide association studies in common cancers: what have we learnt? Curr Opin Genet Dev 2010; 20:201-209.
15. Fletcher O, Houlston RS. Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 2010; 10:353-361.
16. Brennan P, Hainaut P, Boffetta P. Genetics of lung-cancer susceptibility. Lancet Oncol 2010. [Epub ahead of print]
17. Liu H, Wang B, Han C. Meta-analysis of genome-wide and replication association studies on prostate cancer. Prostate 2010. [Epub ahead ofprint]
18. Galvan A, Ioannidis JP, Dragani TA. Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. Trends Genet 2010; 26:132-141.
19. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991; 88:10124-10128. (Pubitemid 21915787)
20. Hainaut P, Pfeifer GP. Patterns of p53 G->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 2001; 22:367-374. (Pubitemid 32203813)
21. Pfeifer GP, Denissenko MF, Olivier M, et al. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002; 21:7435-7451. (Pubitemid 35305599)
22. Yoon JH, Smith LE, Feng Z, et al. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]-pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers. Cancer Res 2001; 61:7110-7117. (Pubitemid 32946502)
23. Besaratinia A, Kim SI, Hainaut P, Pfeifer GP. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure. Gastroenterology 2009; 137:1127-1137.
24. Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321:1801-1806.
25. Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321:1807-1812.
26. Mardis ER, Ding L, Dooling DJ, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009; 361:1058-1066.
27. Pleasance ED, Stephens PJ, O'Meara S, et al. A small-cell lung cancergenome with complex signatures of tobacco exposure. Nature 2010; 463:184-190.
28. Pleasance ED, Cheetham RK, Stephens PJ, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010; 463:191-196.
29. Lee W, Jiang Z, Liu J, et al. The mutation spectrum revealed by paired genomesequences from a lung cancer patient. Nature 2010; 465:473-477.
30. Ding L, Ellis MJ, Li S, et al. Genome remodelling in a basal-like breast cancermetastasis and xenograft. Nature 2010; 464:999-1005.
31. Ding L, Wendl MC, Koboldt DC, Mardis ER. Analysis of next-generation genomic data in cancer: accomplishments and challenges. Hum Mol Genet 2010; 19:R188-196.